Stay updated on MK-3475 + INCB024360 Combo in Cancers Clinical Trial

Sign up to get notified when there's something new on the MK-3475 + INCB024360 Combo in Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MK-3475 + INCB024360 Combo in Cancers Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update or modification in the study details related to the safety, tolerability, and efficacy of combining MK-3475 and INCB024360 in participants with certain cancers.
    Difference
    0.1%
    Check dated 2024-06-06T14:26:38.000Z thumbnail image
  7. Check
    20 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to a detailed description of eligibility criteria for clinical research, including examples such as a person's general health condition or prior treatments. This change provides more specific information about the criteria researchers use to select participants for studies.
    Difference
    48%
    Check dated 2024-05-22T20:54:39.000Z thumbnail image
  8. Check
    42 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T23:01:40.000Z thumbnail image

Stay in the know with updates to MK-3475 + INCB024360 Combo in Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MK-3475 + INCB024360 Combo in Cancers Clinical Trial page.